CM adoption in Drug Substance

Hello Rudi, although I don't have direct access to a resource providing information on the adoption of Continuous Manufacturing in drug substances, it's evident from various research papers that branded/innovator companies have taken the lead in implementing this technology. Additionally, several generic companies from the APAC region, specifically India, China, and Japan, are also making significant progress in CM adoption, however the adoption is slow. Notably, numerous global pharmaceutical companies are establishing CM facilities in the APAC region, with examples such as Singapore, where GSK has set up a small molecule CM facility in 2018. I hope this helps. I would be curious to receive additional insights from fellow experts.